Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.4.1.2 (
acetyl-CoA carboxylase
)
2,876
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rat mammary gland
acetyl-CoA carboxylase
(acetyl-CoA:carbon dioxide ligase (ADP forming),
EC 6.4.1.2
) is rapidly and irreversibly inactivated by micromolar concentrations of S-(4-bromo-2,3-dioxobutyl)-CoA (
BDB
-CoA) or p-hydroxymercuribenzoate (PHMB). Inhibition of both half reactions (i.e., the biotin carboxylation and the carboxyltransferase) catalyzed by
acetyl-CoA carboxylase
closely parallels loss in overall activity (malonyl-CoA synthesis). The presence of a substrate or product (acetyl-CoA, ATP, ADP, Pi) or inhibitor (palmitoyl-CoA) does not protect the enzyme from inhibition caused by
BDB
-CoA or PHMB. On the other hand, citrate, an activator of
acetyl-CoA carboxylase
, affords substantial protection against inhibition by
BDB
-CoA and PHMB. Covalent modification by
BDB
-CoA or PHMB appears to lock
acetyl-CoA carboxylase
in an inactive conformation (15-30 S) that is unable to undergo citrate-induced self-association into the catalytically competent polymeric form.
...
PMID:Inhibitory effects of sulfhydryl reagents on acetyl-CoA carboxylase from rat mammary gland. 614 6